Contec Medical Systems Co Ltd (300869) — Capital Reinvestment Ratio

Latest as of September 2025: 2.11x

Contec Medical Systems Co Ltd (300869) has a Capital Reinvestment Ratio of 2.11x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥4.64 Million) in capital expenditures (CN¥9.82 Million). See Contec Medical Systems Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.11x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥4.64 Million
CNY

Capital Expenditures

CN¥9.82 Million
CNY

Data as of

Sep 2025
Most recent filing

Contec Medical Systems Co Ltd Capital Reinvestment Ratio (2013–2024)

This chart tracks Contec Medical Systems Co Ltd's Capital Reinvestment Ratio across 12 annual periods.

Annual Capital Reinvestment Ratio for Contec Medical Systems Co Ltd (2013–2024)

Year-by-year Capital Reinvestment Ratio for Contec Medical Systems Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see 300869 market cap overview.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.87x CN¥62.34 Million CN¥54.46 Million ▲ +414.5%
2023 0.17x CN¥181.01 Million CN¥30.74 Million ▼ -78.4%
2022 0.79x CN¥103.66 Million CN¥81.45 Million ▼ -96.6%
2021 22.88x CN¥4.65 Million CN¥106.31 Million ▲ +15320.6%
2020 0.15x CN¥597.73 Million CN¥88.67 Million ▲ +0.2%
2019 0.15x CN¥50.22 Million CN¥7.43 Million ▼ -62.8%
2018 0.40x CN¥29.81 Million CN¥11.86 Million ▲ +1430.1%
2017 0.03x CN¥117.61 Million CN¥3.06 Million ▼ -75.1%
2016 0.10x CN¥130.64 Million CN¥13.67 Million ▼ -73.7%
2015 0.40x CN¥35.23 Million CN¥14.00 Million ▼ -4.5%
2014 0.42x CN¥36.45 Million CN¥15.17 Million ▼ -17.8%
2013 0.51x CN¥74.41 Million CN¥37.67 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow